UY31699A1 - Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea - Google Patents

Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea

Info

Publication number
UY31699A1
UY31699A1 UY31699A UY31699A UY31699A1 UY 31699 A1 UY31699 A1 UY 31699A1 UY 31699 A UY31699 A UY 31699A UY 31699 A UY31699 A UY 31699A UY 31699 A1 UY31699 A1 UY 31699A1
Authority
UY
Uruguay
Prior art keywords
low viscosity
injection
triamcinolone acetonide
intravitrea
floculation
Prior art date
Application number
UY31699A
Other languages
English (en)
Spanish (es)
Inventor
Ruma Sarakar
Bhagwati Kabra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31699A1 publication Critical patent/UY31699A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
UY31699A 2008-03-11 2009-03-10 Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea UY31699A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3545908P 2008-03-11 2008-03-11

Publications (1)

Publication Number Publication Date
UY31699A1 true UY31699A1 (es) 2009-05-29

Family

ID=40548758

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31699A UY31699A1 (es) 2008-03-11 2009-03-10 Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea

Country Status (21)

Country Link
US (3) US8128960B2 (enExample)
EP (1) EP2262506B1 (enExample)
JP (1) JP5581227B2 (enExample)
KR (1) KR101555293B1 (enExample)
CN (1) CN101959519B (enExample)
AR (1) AR070824A1 (enExample)
AU (1) AU2009223649B2 (enExample)
BR (1) BRPI0909630B8 (enExample)
CA (1) CA2717605C (enExample)
CL (1) CL2009000573A1 (enExample)
DK (1) DK2262506T3 (enExample)
ES (1) ES2471122T3 (enExample)
MX (1) MX2010009974A (enExample)
PL (1) PL2262506T3 (enExample)
PT (1) PT2262506E (enExample)
RU (1) RU2481842C2 (enExample)
SI (1) SI2262506T1 (enExample)
TW (1) TWI468165B (enExample)
UY (1) UY31699A1 (enExample)
WO (1) WO2009114521A1 (enExample)
ZA (1) ZA201005839B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
SI2262506T1 (sl) * 2008-03-11 2014-07-31 Alcon Research, Ltd. Močno flokulirane suspenzije triamcinolon acetonida z nizko viskoznostjo za intravitrealno injekcijo
MX2011005586A (es) * 2008-12-22 2011-06-20 Alcon Res Ltd Composiciones de soluciones oculares topicas para suministrar concentraciones efectivas de agente activo al segmento posterior del ojo.
CN106214321B (zh) 2010-10-15 2018-08-28 科尼尔赛德生物医学公司 用于进入眼睛的装置
CN102008488B (zh) * 2010-11-24 2012-10-10 广州固志医药科技有限公司 一种曲安奈德眼用制剂及其制备方法
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
EP3721872B1 (en) * 2012-11-08 2025-01-22 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
EP2991706B1 (en) 2013-05-03 2021-06-23 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
WO2014197317A1 (en) 2013-06-03 2014-12-11 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
US9694145B1 (en) 2016-03-29 2017-07-04 Joseph Onorato Auto-injector systems and method for delivering cyst medication on demand
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
CN110177527B (zh) 2016-08-12 2022-02-01 科尼尔赛德生物医学公司 用于调节药剂递送用针的插入深度的装置和方法
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
EP3737381A4 (en) * 2018-01-10 2021-11-10 Eye Co Pty Ltd MEDICAL DEVICE AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A DISEASE OR CONDITION OF THE EYE
USD893715S1 (en) 2018-11-06 2020-08-18 Joseph Onorato Measurement guide for a cyst, lesion or skin disorder
KR20220019667A (ko) 2019-04-16 2022-02-17 클리어사이드 바이오메디컬, 인코포레이드 주사 가능한 트리암시놀론 제형
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
CN114010593A (zh) * 2021-11-23 2022-02-08 莱默(北京)药业科技有限公司 一种曲安奈德混悬注射液及制备方法
CN115969784B (zh) * 2022-12-26 2025-10-21 昆明积大制药股份有限公司 曲安奈德注射液的制备方法
WO2025114562A1 (en) * 2023-11-30 2025-06-05 Institut National de la Santé et de la Recherche Médicale Intravitreal spironolactone suspension

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
WO1995003807A1 (en) 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
WO1996020712A1 (en) 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
EP1104302A4 (en) 1998-07-10 2006-08-09 Retmed Pty Ltd PROPHYLACTIC TREATMENTS OF BLOOD VESSEL NEOFORMATION IN MACULAR DEGENERATION
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AUPQ496500A0 (en) 2000-01-06 2000-02-03 University Of Sydney, The Kit
US6395294B1 (en) 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
US6656505B2 (en) * 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
AU2001278779A1 (en) * 2000-08-25 2002-03-04 Senju Pharmaceutical Co. Ltd. Aqueous suspension preparations
CN1553804A (zh) * 2001-07-09 2004-12-08 用于炎性疾病治疗的联合形式
US20030129242A1 (en) 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
MXPA05008561A (es) 2003-02-20 2005-11-04 Alcon Inc Uso de esteroides para tratar personas que sufren de trastornos oculares.
US20040186084A1 (en) 2003-03-21 2004-09-23 Akorn, Inc. Triamcinolone formulations and methods for their preparation and use
EP1663144A1 (en) * 2003-09-23 2006-06-07 Alcon, Inc. Triamcinolone acetonide and anecortave acetate formulations for injection
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
CN1905856A (zh) * 2003-12-23 2007-01-31 阿尔扎公司 用于增加受控递送的药物组合物的溶解度的方法和剂型
WO2005072701A1 (en) 2004-01-20 2005-08-11 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
EP1752152A4 (en) 2004-05-31 2011-02-16 Senju Pharma Co MEANS FOR VISUALIZING TRANSPARENT WEAVE
US20060089590A1 (en) 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
CA2588433A1 (en) 2004-11-17 2006-05-26 Michael R. Robinson Steroid formulation and methods of treatment using same
CN101119733A (zh) * 2005-02-18 2008-02-06 参天制药株式会社 减轻或避免甾族化合物副作用的方法
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
ITRM20050547A1 (it) 2005-11-04 2007-05-05 Sooft Italia S R L Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico.
SI2262506T1 (sl) * 2008-03-11 2014-07-31 Alcon Research, Ltd. Močno flokulirane suspenzije triamcinolon acetonida z nizko viskoznostjo za intravitrealno injekcijo

Also Published As

Publication number Publication date
JP2011513492A (ja) 2011-04-28
AR070824A1 (es) 2010-05-05
TW200940071A (en) 2009-10-01
CN101959519A (zh) 2011-01-26
AU2009223649B2 (en) 2013-08-29
US20120116216A1 (en) 2012-05-10
BRPI0909630A2 (pt) 2015-09-22
US20090233890A1 (en) 2009-09-17
AU2009223649A1 (en) 2009-09-17
PL2262506T3 (pl) 2014-09-30
MX2010009974A (es) 2010-09-30
BRPI0909630B8 (pt) 2021-05-25
PT2262506E (pt) 2014-06-24
CA2717605A1 (en) 2009-09-17
DK2262506T3 (da) 2014-06-10
HK1146464A1 (en) 2011-06-10
EP2262506B1 (en) 2014-05-07
US20120115829A1 (en) 2012-05-10
CN101959519B (zh) 2013-03-20
KR20100127267A (ko) 2010-12-03
WO2009114521A1 (en) 2009-09-17
KR101555293B1 (ko) 2015-10-06
SI2262506T1 (sl) 2014-07-31
TWI468165B (zh) 2015-01-11
RU2481842C2 (ru) 2013-05-20
US8211880B2 (en) 2012-07-03
ES2471122T3 (es) 2014-06-25
EP2262506A1 (en) 2010-12-22
US8128960B2 (en) 2012-03-06
RU2010141542A (ru) 2012-04-20
BRPI0909630B1 (pt) 2019-03-26
CA2717605C (en) 2012-05-15
CL2009000573A1 (es) 2010-01-04
JP5581227B2 (ja) 2014-08-27
ZA201005839B (en) 2011-10-26

Similar Documents

Publication Publication Date Title
UY31699A1 (es) Suspensiones de acetonido de triamcinolona de baja viscosidad y elevada floculacion para inyeccion intravitrea
SV2008003071A (es) Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40
ES2530170T3 (es) Material de filtro transparente
BR112012016021A8 (pt) Formulações estáveis para liofilização de partículas terapêuticas
DE602006008625D1 (de) Polymermicellen für die arzneistoffzufuhr
MX2022003458A (es) Una composicion farmaceutica que comprende nanoparticulas hibridas amorfas estables, de al menos un inhibidor de proteina quinasa y al menos un componente estabilizador polimerico y formador de matriz.
ATE522593T1 (de) Textilpflegemittel mit formaldehydfängern
UY28252A1 (es) Compuestos de benzopirano útiles para tratar estados inflamatorios
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
CR20110218A (es) Composiciones de aceite agroquímicas que comprenden adyuvantes alquipolisiloxanos en condición de silicona alta
PA8854101A1 (es) Derivados de imidazol bicíclicos sustituidos como moduladores de gamma secretasa
AR060739A1 (es) Composiciones orales que comprenden polimeros de siloxano
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
PA8769401A1 (es) Hormigon con alta funcionalidad mediante control de proporciòn de material fino-a- granular
BR112012024131A2 (pt) Emulsões úteis em bebidas.
MX387756B (es) Composiciones de matríces extracelulares.
BR112014032801A2 (pt) composições líquidas de racecadotril
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
MX2016004885A (es) Composicion de polimero funcionalizado.
CL2022003194A1 (es) Composiciones farmacéuticas inyectables y usos de las mismas
UY28247A1 (es) Compuestos de benzopirano para uso en el tratamiento y la prevención de afecciones relacionadas con la inflamación.
EA201070484A1 (ru) Новые конъюгаты нейртурина для фармацевтического применения
MX2010003914A (es) Nuevas composiciones a base de taxoides.
BR112016022628A2 (pt) Composição, processo para produzir um copolímero em bloco, e, copolímero em bloco
MX375183B (es) Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas.

Legal Events

Date Code Title Description
105 Application deemed to be withdrawn (no grant fee paid)

Effective date: 20201218